Hereditary Angioedema in Women: Special Considerations for Prevention and Care

Hereditary Angioedema in Women

Hereditary Angioedema in Women
Adobe Stock
Hereditary angioedema (HAE) is a rare genetic condition that causes episodes of pronounced swelling in parts of the body including the face, hands, feet, genitals, abdomen, and airways. While HAE affects both men and women, evidence suggests that women have more delays to diagnosis, greater burden of disease, poorer control of their attacks, and a reduced quality of life compared with men.

For many women, managing HAE is particularly complex because hormonal changes, such as those that occur during puberty, menstruation, pregnancy, and menopause, can influence the frequency and severity of attacks — making life transitions that are already challenging even more difficult.

Researchers have long recognized that women with HAE tend to experience more frequent and intense episodes than men, and those differences are thought to be linked to estrogen.

Understanding how hormones and life stages affect HAE can help women work with their care team to plan ahead, prevent attacks, and improve their quality of life.

The Role of Estrogen in HAE

Estrogen plays a major role in how HAE behaves in women. Higher levels of this hormone, whether naturally occurring or due to contraceptives or hormone therapy, can increase bradykinin, the chemical that triggers swelling in HAE.

As a result, women often experience their first attacks or worsening symptoms at times when estrogen levels rise. Research suggests that hormonal fluctuations are one of the most important factors influencing how HAE affects women.

Experts emphasize the need for individualized treatment and careful management around reproductive milestones to minimize the impact of estrogen on HAE.

Puberty and Menstruation

For many girls, HAE symptoms begin or become more noticeable around puberty. The increase in estrogen that accompanies this stage of life can cause attacks to occur more frequently or be more severe.

An estimated 35 percent of women report more frequent attacks during their period, and 14 percent say ovulation is a trigger.

Because of the role hormones play in attacks, immunologists and allergists who treat HAE work closely with their female patients’ primary care providers or ob-gyns, says Rita Kachru, MD, an immunologist at UCLA Health in Santa Monica.

“If we start seeing patterns of attacks occurring during ovulation or occurring during menstruation or a few days before your period starts, we want to make sure that [your] hormone levels are as stable or optimized as possible so that we can better regulate these attacks,” says Dr. Kachru.

Treatment plans may include on-demand therapy to manage acute symptoms, or a prophylactic medication to help prevent attacks from occurring.

Progestin-only birth control pills may also be used to lessen HAE attacks.

Education and self-management training are key for teens and young women. Having a clear plan for treating attacks, avoiding known triggers, and understanding when to seek emergency care can help reduce anxiety and promote independence.

Some young women report that their early symptoms were dismissed as “stress” or “hormonal,” leading to years-long delays in diagnosis. In an analysis of women’s experiences with HAE, several participants described feeling disbelieved or told their illness was “psychological,” reflecting the broader issue of a bias in medicine.

Contraception

Women of childbearing age should discuss options for contraception with an ob-gyn or another healthcare professional who treats people with HAE. Estrogen-containing birth control pills, patches, or rings can worsen HAE by raising bradykinin levels, potentially triggering attacks or making them more frequent. For some women, these types of birth control have triggered the first instance of an HAE attack.

Progestin-only methods (such as the mini-pill) or intrauterine devices (IUDs) are better tolerated options for women with HAE and may even reduce the number of attacks in certain types of HAE.

Pregnancy

Pregnancy affects each woman with HAE differently. The frequency of attacks increases in about one-third of women, decreases in one-third, and stays the same in the remaining third.

The preferred treatment for acute attacks and long-term prevention during pregnancy is plasma-derived C1 inhibitor. Anabolic androgens, which are sometimes used to prevent attacks, are contraindicated during pregnancy because they may affect fetal development. Tranexamic acid, also sometimes used as a preventive medication, may be considered in specific cases, but its safety in pregnancy is not well studied.

Beyond the physical aspects, pregnancy can bring emotional challenges. Many women describe fear or guilt about passing HAE to their children and anticipatory worrying about the future suffering of their unborn child.

Close monitoring by both an obstetrician and an immunologist familiar with HAE is crucial. It’s important to talk about your concerns with your providers or with a mental health professional so that you can get the support you need during your pregnancy.

Labor and Delivery

Labor and delivery require careful coordination between the obstetric, anesthesia, and immunology teams to discuss the plan in case of an attack, though it’s uncommon to have an attack during labor. Typically, short-term prophylactic treatment isn’t needed.

After delivery, some women may have angioedema (swelling) of the vulva. On-demand medication should be kept ready for emergency use.

Vaginal delivery is generally preferred, because cesarean section (also known as a C-section) carries a higher risk of triggering an HAE attack. For women who do need a C-section, short-term prophylaxis with plasma-derived C1 inhibitor before surgery is recommended.

In case of a planned C-section, it’s recommended that general anesthesia or intubation be avoided because it can irritate the airway and increase the risk of swelling.

Women with HAE often express anxiety about delivery because of the unpredictability of attacks. Having a clear birth plan that specifies emergency medications and contacts can help reduce fear and improve confidence during delivery.

Breastfeeding

Breastfeeding can increase HAE attacks, which are thought to be caused by an increase in prolactin levels. (Prolactin is one of the main hormones involved in breastfeeding.) Typically, when women stop breastfeeding, the number of attacks go down.

For women who need treatment while breastfeeding, plasma-derived or recombinant C1 inhibitors are considered safe. As with pregnancy, tranexamic acid and anabolic androgens should be avoided while breastfeeding.

Support during this stage is essential. New moms with HAE may feel pressure to continue breastfeeding despite fatigue, sleep deprivation, or the fear of triggering attacks. Coordination between the immunology team, primary care provider, and lactation consultant can help mothers make informed, safe choices that balance their health with their feeding goals.

Menopause

Menopause brings another hormonal shift that can affect HAE — but in unpredictable ways. A little over half of women report no change in symptoms, about one-third say symptoms get worse, and 13 percent have improvement.

Hot flashes and night sweats are common symptoms of menopause, but estrogen-based hormone replacement therapy (including phytoestrogens) isn’t recommended. Vaginal estrogens are okay because the systemic dose is so low.

Treatments such as lifestyle adjustments, cognitive behavioral therapy, or nonhormonal medications are safer alternatives. As with other stages of life, the key is individualized care guided by an allergist-immunologist and gynecologist familiar with both HAE and women’s health.

Emotional and Psychosocial Support

Beyond the medical management of HAE, the emotional toll can be significant. Many women report feelings of isolation, anxiety about attacks, and frustration with being misunderstood by healthcare providers or family members.

Mental health support, whether through counseling, peer groups, or patient organizations such as the U.S. Hereditary Angioedema Association (HAEA), can play a vital role in overall well-being. Integrating psychological care into HAE management helps women feel heard, supported, and empowered to manage both the physical and emotional challenges of the condition.

The Takeaway

  • Hormonal changes throughout life — from puberty to menopause — can influence how hereditary angioedema affects women.
  • Estrogen can trigger or worsen attacks, so contraception, pregnancy, and menopause management require careful coordination with providers familiar with HAE.
  • Pregnancy and breastfeeding may require HAE medication changes to prevent the fetus from potential harm.
  • Connecting with knowledgeable specialists and patient groups can make living with HAE more manageable and less isolating.
EDITORIAL SOURCES
Everyday Health follows strict sourcing guidelines to ensure the accuracy of its content, outlined in our editorial policy. We use only trustworthy sources, including peer-reviewed studies, board-certified medical experts, patients with lived experience, and information from top institutions.
Resources
  1. Zwiener R et al. Burden of Illness in Female and Male Adult Patients with Hereditary Angioedema: Findings From a Multinational Survey. The Journal of Allergy and Clinical Immunology. February 2024.
  2. Yakaboski E et al. Hereditary Angioedema: Special Considerations in Women. Allergy and Asthma Proceedings. November 1, 2020.
  3. Busse PJ et al. US HAEA Medical Advisory Board 2020 Guidelines for the Management of Hereditary Angioedema. The Journal of Allergy and Clinical Immunology in Practice. January 2021.
  4. Haywood S et al. Women’s Experiences of Living with Hereditary Angioedema: A Secondary Qualitative Analysis. 2025 Festival of Psychology in the Midlands. September 8, 2025.

Stephen H. Kimura, MD

Medical Reviewer

Stephen Kimura, MD, is a board-certified allergist and immunologist. He's been in private practice in Pensacola, Florida, for the past 25 years with the Medical Center Clinic, a multi-specialty practice. He enjoys working with people who were seen as patients as children and now are bringing their children to him for care.

Dr. Kimura received his medical degree from the University of Kansas School of Medicine. He went on to complete his residency at Butterworth Hospital in Grand Rapids, Michigan, and later received additional training in allergy and immunology during his fellowship at the University of Kansas.

Kimura grew up in Hawaii, and says he has many happy memories of coming home from school to go surfing, snorkeling, and swimming at the beaches there.

Becky Upham, MA

Becky Upham

Author

Becky Upham has worked throughout the health and wellness world for over 25 years. She's been a race director, a team recruiter for the Leukemia and Lymphoma Society, a salesperson for a major pharmaceutical company, a blogger for Moogfest, a communications manager for Mission Health, a fitness instructor, and a health coach.

Upham majored in English at the University of North Carolina and has a master's in English writing from Hollins University.

Upham enjoys teaching cycling classes, running, reading fiction, and making playlists.